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eparin-binding EGF-like growth factor (HB-EGF) is
ﬁrst synthesized as a membrane-anchored form
(proHB-EGF), and its soluble form (sHB-EGF) is
released by ectodomain shedding from proHB-EGF. To
examine the signiﬁcance of proHB-EGF processing in vivo,
we generated mutant mice by targeted gene replacement,
expressing either an uncleavable form (HB
 
uc
 
) or a trans-
membrane domain–truncated form (HB
 
 
 
tm
 
) of the molecule.
H
 
HB
 
uc/uc
 
 mice developed severe heart failure and enlarged
heart valves, phenotypes similar to those in proHB-EGF null
mice. On the other hand, mice carrying HB
 
 
 
tm
 
 exhibited
severe hyperplasia in both skin and heart. These results
indicate that ectodomain shedding of proHB-EGF is essential
for HB-EGF function in vivo, and that this process requires
strict control.
 
Introduction
 
Heparin-binding EGF-like growth factor (HB-EGF), a
member of the EGF family, binds the EGF receptor (EGFR)
and ErbB4 to initiate signaling (Higashiyama et al., 1991;
Elenius et al., 1997). Like other EGF family members (for
review see Massague and Pandiella, 1993), HB-EGF is first
synthesized as a membrane-anchored form (proHB-EGF),
and then the soluble form (sHB-EGF) is released from the
cell surface by ectodomain shedding (Goishi et al., 1995).
sHB-EGF is a diffusible factor with potent mitogenic
and chemoattractant activities for a number of cell types.
ProHB-EGF forms a complex with other membrane proteins
at the cell–cell contact site and transduces biological signals
to neighboring cells in a nondiffusible manner (for review
see Iwamoto and Mekada, 2000). Thus, in addition to being
a precursor of sHB-EGF, proHB-EGF is thought to be a
biologically active molecule itself. Several studies in vitro
have revealed that a number of signaling molecules control
the ectodomain shedding of proHB-EGF (Izumi et al.,
1998; Umata et al., 2001; Takenobu et al., 2003), implying
that strict control of ectodomain shedding is critical for
HB-EGF function.
Recently, we demonstrated that HB-EGF is critical for
proper heart development and function by the analyses of
HB-EGF null mice (Iwamoto et al., 2003). However, it
remains unclear which forms of HB-EGF are necessary for
these process. The relative roles of either proHB-EGF or
sHB-EGF and the significance of the control of ectodomain
shedding in vivo have yet to be determined. To address these
issues, we generated two kinds of mutant mice, by targeted
gene replacement, that express either an uncleavable (HB
 
uc
 
)
or a transmembrane domain–truncated form (HB
 
 
 
tm
 
) of
proHB-EGF. Analysis of these mutant lines indicates that
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proHB-EGF shedding is essential in vivo and that this pro-
cess must be controlled.
 
Results and discussion
 
Generation of mice expressing uncleavable 
proHB-EGF mutant
 
An uncleavable form of proHB-EGF was generated by creat-
ing double point mutations, L148S/P149T, in the jux-
tamembrane domain (designated HB
 
uc
 
) (Fig. 1 A). As shown
previously in cases of each single point mutation (Hirata et
al., 2001), HB-UC (a product of HB
 
uc
 
) was also resistant to
ectodomain shedding in response to various shedding-induc-
ing stimuli, while the other biological properties of HB-UC
were similar to those of WT proHB-EGF (Fig. S1, A–C, and
supplemental Results, available at http://www.jcb.org/cgi/
content/full/jcb.200307035/DC1). To assess the biological
significance of proHB-EGF ectodomain shedding, we cre-
ated mutant mice expressing HB-UC instead of WT proHB-
EGF by targeted replacement of the proHB-EGF gene with
HB
 
uc
 
 cDNA (Fig. S2, supplemental Results, and supplemen-
tal Materials and methods, available at http://www.jcb.org/
cgi/content/full/jcb.200307035/DC1). Homozygous mice
(HB
 
uc/uc
 
) were born at the predicted Mendelian frequency.
Northern blotting of the transcripts obtained from adult
mice indicated that the WT and HB
 
uc
 
 alleles were expressed
equally in heart, lung, and kidney (Fig. 1 B).
We examined whether HB-UC was resistant to ecto-
domain shedding in mice (Fig. 1 C). We used adult mouse
skin samples obtained from HB
 
uc/uc
 
 mice and HB
 
lox/lox
 
 mice
as a control. In HB
 
lox/lox
 
 mice, the proHB-EGF locus was
replaced with WT proHB-EGF cDNA (Iwamoto et al.,
2003), making HB
 
lox/lox
 
 mice more suitable controls than
WT mice. In adult mouse skin, HB-EGF protein bands
were hardly detected in samples obtained from adult HB
 
uc/uc
 
and HB
 
lox/lox
 
 mice. All-trans retinoic acid (tRA) is known to
induce HB-EGF expression, followed by epidermal hyper-
plasia (Xiao et al., 1999). When tRA was applied to skin on
the backs of mice, proHB-EGF protein was induced and
clearly detected in samples from HB
 
lox/lox
 
 and HB
 
uc/uc
 
 mice
by using an antibody against the proHB-EGF ectodomain.
Under these conditions, the band corresponding to sHB-
EGF was also detected in HB
 
lox/lox
 
 mice, but not in HB
 
uc/uc
 
mice. An antibody recognizing the cytoplasmic domain of
proHB-EGF did not detect this sHB-EGF band (unpub-
lished data), confirming that this band corresponds to
secreted HB-EGF. When tRA-induced skin was further
treated with 
 
O
 
-tetradecanoylphorbol-13-acetate (TPA), the
sHB-EGF band appeared more intensely in HB
 
lox/lox
 
 mice.
However, the sHB-EGF band was not detected in samples
from tRA 
 
  
 
TPA–treated HB
 
uc/uc
 
 mice. These results indi-
cate that ectodomain shedding of proHB-EGF is severely
impaired in HB
 
uc/uc
 
 mice.
 
Uncleavable proHB-EGF mutation causes cardiac 
dysfunction and heart valve malformation
 
Recently, we showed that HB-EGF null mice (HB
 
del/del
 
) have
defects in cardiac chamber dilation and cardiac valve malfor-
mation (Iwamoto et al., 2003). Therefore, we analyzed the
heart phenotype in HB
 
uc/uc
 
 mice. Autopsies of HB
 
uc/uc
 
 mice
revealed massive enlargement of the heart. Histological analy-
sis showed that wall thickness was reduced, accompanied by
sporadic fibrosis in 12-wk-old HB
 
uc/uc
 
 mice (Fig. 2, A–D).
These phenotypes are highly similar to those observed in HB-
EGF null mice (Iwamoto et al., 2003) and ErbB2 conditional
knockout mice (Crone et al., 2002; Ozcelik et al., 2002).
Transthoracic echocardiography indicated marked dila-
tion and poor left ventricular contraction in HB
 
uc/uc
 
 mice
(Fig. 2, E and F). Dilation could be detected in 4-wk-old
mice, though the physical activity level and appearance was
indistinguishable between WT and HB
 
uc/uc
 
 mice. Mutant
mice also had reduced cardiac wall movement, and ventricu-
lar fractional shortening (FS), a representative measure of
systolic function, was greatly reduced.
In addition to the ventricular chamber abnormality, heart
valve malformation was also observed in HB
 
uc/uc
 
 mice as in
HB-EGF null mice (Iwamoto et al., 2003; Jackson et al.,
Figure 1. Expression and uncleavability of HB-UC in HB
uc knock-in 
mice. (A) Schematic structures of the HB-UC constructs. HBD, 
heparin-binding domain; EGF, EGF-like domain; TM, transmembrane 
domain. (B) Northern blot analysis of HB-EGF mRNA from adult WT 
( / ) and HB
uc/uc (uc/uc) mice. The size of the transcript from HB
uc 
is 100 bp larger than that from the WT gene due to neo cassette 
integration. (C) Uncleavable HB-UC in tRA- and TPA-treated skin. 
HB-EGF immunoblots of protein extracted and concentrated by 
heparin-Sepharose from 11-wk-old control (lox/lox) or HB
uc/uc 
(uc/uc) mouse skin, treated with tRA (tRA), TPA after tRA treatment 
(tRA   TPA), or no treatment ( ).T
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2003) and EGFR knockout mice (Chen et al., 2000). Histo-
logical analysis of E17.5 embryonic HB
 
uc/uc
 
 hearts showed
enlarged semilunar (aortic and pulmonic) and atrioventricu-
lar (mitral and tricuspid) valves (Fig. 3, A–D). Scoring of
cardiac valve size in E17.5 hearts revealed enlarged semilu-
nar and atrioventricular valves in HB
 
uc/uc
 
 mice (Fig. 3 E). No
overt abnormality was observed in HB
 
lox/lox
 
 heart chambers
or valves (Iwamoto et al., 2003), indicating that heart abnor-
malities in HB
 
uc/uc
 
 mice were not due to a nonspecific effect
of cDNA knock-in.
The similar heart defects displayed in HB
 
del/del
 
 and HB
 
uc/uc
 
mice indicate that the process of ectodomain shedding is es-
sential for HB-EGF function in normal cardiac valve develop-
ment and cardiomyocyte function, and that soluble HB-EGF
is required for these processes. We also examined whether
proHB-EGF has any in vivo physiological role aside from act-
ing as the sHB-EGF precursor. Interestingly, HB
 
del/del
 
 mice
Figure 2. Histological and echocardiographic analysis of hearts 
from adult HB
uc/uc mice. (A and B) Hematoxylin-eosin staining of 
transverse sections through hearts of 12-wk-old mice at the papillary 
muscle level. Bar, 3 mm. (C and D) High magnification pictures. 
Sections were stained with Azan-Mallory. Massive fibrosis (blue stain) 
is present in 12-wk-old HB
uc/uc heart throughout the vessel wall. 
Bar, 250  m. (E and F) Echocardiographic analyses of hearts from 
WT ( / ) and HB
uc/uc (uc/uc) mice. (E) Representative images 
of M-mode analyses are shown. Arrows indicate end-diastolic (d) 
and end-systolic (s) dimensions, respectively. (F) Physiological 
parameters of WT versus HB
uc/uc hearts in 12-wk-old mice. HR, 
heart rate; sBP and dBP, systolic and diastolic blood pressure; 
LVDd and LVDs, left ventricular end diastolic and end systolic 
internal dimensions; FS, percent fractional shortening calculated as 
[(LVDd   LVDs)/LVDd]   100. All values   SEM.
Figure 3. Cardiac valve defects in HB
uc/uc mice. (A–D) Histological 
analysis of cardiac valves. Shown are hematoxylin-eosin–stained 
longitudinal sections of hearts of E17.5 embryos. Mice are WT 
(A and C) and HB
uc/uc (B and D). Pulmonic (A and B) and mitral 
valves (C and D) are indicated by asterisks. Aortic and tricuspid valves 
were also enlarged (not depicted). Bar, 150  m. (E) Measurement of 
cardiac valve size. The largest diameters of each valve in serial sections 
of E17.5 embryos of WT (black dots, n   5), HB
uc/  (blue dots, n   9), 
and HB
uc/uc (red dots, n   4) hearts were measured. pv, pulmonic 
valve; av, aortic valve; tv, tricuspid valve; mv, mitral valve.T
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displayed a shorter life span than HB
 
uc/uc
 
 mice. Half of HB
 
uc/uc
 
mice survive over 18 wk, while 
 
 
 
60% of HB
 
del/del
 
 mice died
in the first postnatal week. These differences between HB
 
del/del
 
and HB
 
uc/uc
 
 mice suggest that proHB-EGF may function in
unidentified developmental processes. Further comparison of
the phenotypes between HB
 
del/del
 
 and HB
 
uc/uc
 
 mice may help
us answer this question.
 
Generation of mice expressing soluble 
proHB-EGF mutant
 
Although studies of HB
 
uc/uc
 
 mice indicated that ectodomain
shedding of proHB-EGF and release of sHB-EGF is neces-
sary for proper HB-EGF function in vivo, the physiological
importance of the control of proHB-EGF ectodomain shed-
ding remained unclear. To address this issue, we prepared
another mouse mutant that only expresses sHB-EGF. The
transmembrane domain–truncated mutant (HB
 
 
 
tm
 
) was
generated by insertion of a stop codon between Leu
 
148
 
 and
Pro
 
149
 
 (Fig. 4 A), the major site for proHB-EGF processing
(Higashiyama et al., 1992). Mitogenic activity was similar
between HB-
 
 
 
TM (product of HB
 
 
 
tm
 
) and WT sHB-EGF
derived from proHB-EGF shedding, but HB-
 
 
 
TM is se-
creted at much higher levels than WT sHB-EGF (Fig. S1,
D–G, and supplemental Results). The targeting construct
Figure 4. HB
 tm knock-in mice. (A) Schematic structures of the HB- TM construct. (B–D) Phenotype of HB
 tm chimeric mice. P0 (B) and P9 
(C) wild-type (WT) and HB
 tm chimeric ( tm) mice and P14 HB
 tm chimeric mice (D) are shown. (E) Phenotype of P6 HB
 tm heterozygous 
mice ( / tm) and wild-type littermates ( / ). (F and G) Expression of HB
 tm in the targeted mice. (F) Transcription of the HB
 tm allele was 
assessed by RT-PCR analysis of tissues (skin and heart) from P14 wild-type (WT) and chimeric ( tm) mice. Primer sets detecting the wild-type 
(p1 and p2) or HB
 tm allele (p1 and p3) transcripts are indicated below each gel. EGF, EGF-like domain; TM, transmembrane domain. RT-PCR 
with primer sets for the detection of GAPDH transcripts is shown in the lower panel as a loading control. (G) Detection of sHB-EGF in the skin. 
Immunoblots of proteins (150  g/lane) extracted from P1 WT ( / ) or heterozygous ( / tm) mouse skin were performed using anti–proHB-EGF 
antibodies that recognize either intracellular (Cyto) or extracellular regions (Ecto) of HB-EGF. The extracellular-specific antibody detects 
sHB-EGF more efficiently than proHB-EGF. Four major bands corresponding to sHB-EGF, resulting from multiple processing and glycosylation 
sites in the HB-EGF NH2-terminal region, were detected in HB
 tm heterozygous mice. Arrowheads indicate the bands corresponding to 
proHB-EGF. The asterisk indicates nonspecific bands.T
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for HB
 tm is similar to that for HB
uc. One allele of the
proHB-EGF gene in ES cells was replaced with HB
 tm
through homologous recombination (Fig. S2, supplemental
Results, and supplemental Materials and methods). Chi-
meric mice carrying HB
 tm were generated from these ES
clones. Most chimeric founders exhibited abnormally small
bodies and thickened skin (Fig. 4, B–D). The majority of
these mice died before or during the neonatal stage (unpub-
lished data). A few mice, however, survived and were fertile.
Most of the resulting F1 heterozygotes carrying the HB
 tm
allele also died before or during the neonatal stage (unpub-
lished data), displaying a more severe phenotype than that
seen in chimeric mice (Fig. 4 E).
We confirmed the expression of the HB
 tm cDNA in chi-
meric mice by RT-PCR of skin and heart specimens (Fig. 4
F). Transcripts derived from the WT proHB-EGF allele
were detected in both WT and chimeric tissues, while those
derived from the HB
 tm allele were only identified in chi-
meric mice. Expression of HB
 tm was also confirmed at the
protein level using anti–HB-EGF antibody, specific for the
extracellular domain of proHB-EGF. In heterozygote skin,
significant quantities of soluble HB-EGF were detected,
whereas sHB-EGF protein was only barely detectable in WT
skin (Fig. 4 G). The quantities of proHB-EGF with a mo-
lecular mass of  19 kD, detected by an anti–HB-EGF anti-
body specific for the cytoplasmic domain, displayed a con-
Figure 5. Abnormal skin and heart development in HB
 tm-
containing mice. (A–F) Back skin from either P3 wild-type (WT) 
or HB
 tm chimeric mice ( tm) was transplanted onto the backs of 
Balb/c nu/nu mice. (A) Hematoxylin and eosin–stained transverse 
sections of back skin from grafted nude mice. (B–F) K1, K10, K5, 
K6, and Ki-67: keratin 1, 10, 5, or 6 and Ki-67 localization in the 
epidermis of back skin from grafted nude mice. K1, keratin 1; 
K10, keratin 10; K5, keratin 5; K6, keratin 6. Bar, 50  m. 
(G–J) Histological sections of hearts from E16.5 (G and H) and P0 
(I and J) WT (WT) or HB
 tm chimeric mice ( tm). Lower magnifi-
cations (G and I) and higher magnifications (H and J) are shown. 
Bars: (G and I) 1 mm; (H and J) 50  m.T
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comitant decrease in heterozygote skin relative to the levels
seen in wild-type skin (Fig. 4 G).
Dysregulated release of HB-EGF induces developmental 
abnormalities with hyperplasia
The most obvious phenotype of HB
 tm-carrying mice, dis-
tinguishing them from WT mice, was the presence of ab-
normal elephant-like skin (Figs. 4, B–E). HB
 tm mice have
short lives; thus to further study the epidermal hyperplasia,
back skin was transplanted from P3 WT or HB
 tm chimeric
mice onto the backs of Balb/c nu/nu mice for 2 wk. This
transplantation method also allowed for the specific exami-
nation of the effects of HB
 tm in the skin in an animal with
otherwise normal expression and processing of HB-EGF.
Histological examination revealed severe epidermal hyper-
plasia, accompanied by the presence of large, disorganized,
hair follicle–like structures (Fig. 5 A). Immunohistochem-
istry of epidermal marker proteins revealed perturbed dif-
ferentiation and proliferation of keratinocytes (Fig. 5,
B–F). Keratin 5, normally expressed by both mitotically ac-
tive, basal layer keratinocytes and hair follicles, was de-
tected in the suprabasal epidermis of chimeric mice (Fig. 5
D). Keratin 1, normally expressed by differentiating kerati-
nocytes in the suprabasal epidermis, but not by the cells
of the hair follicle (Heid et al., 1988), was expressed in
the hair follicle–like structures of chimeric mice (Fig. 5
B). Additionally, keratin 10, a differentiating keratinocyte
marker, was down-regulated in chimeric mice (Fig. 5 C).
Keratin 6, expressed predominantly in hair follicle cells,
and at lower levels in the suprabasal epidermis, was de-
tected throughout the epidermis of chimeric mice (Fig. 5
E), consistent with the induction of keratin 6 expression by
epidermal hyperproliferation (Werner et al., 1993). The
expression of Ki-67, a nuclear mitotic marker, was also in-
creased in the basal layer of chimeric skin compared with
levels seen in WT (Fig. 5 F), indicating that HB
 tm expres-
sion accelerates basal layer keratinocyte proliferation. No
overt abnormality was observed in the skin area surround-
ing the transplanted skin, suggesting that the abnormality
in the transplanted skin is due to the action of HB- TM in
a manner of autocrine or paracrine in limited distance,
rather than paracrine in long distance.
Morphological abnormalities were also found in the heart
of HB
 tm mice. Histological specimens showed ventricular
hypertrophy in hearts from HB
 tm E16.5 embryos (Fig. 5 G)
and P0 mice (Fig. 5 I). HB-EGF is expressed in cardiomyo-
cytes (Iwamoto et al., 2003), consistent with the present re-
sults. The cardiac muscle fibers in chimeric mice were loose,
with enlarged nuclei (Fig. 5, H and J). These results suggest
that expression of HB
 tm reduces cardiomyocyte differentia-
tion or terminates proliferation. These cardiac developmen-
tal abnormalities may be the primary cause of early death in
HB
 tm mice.
The phenotype observed in HB
 tm mice is likely due to
dysregulated secretion of sHB-EGF. In normal conditions, a
portion of proHB-EGF molecules are converted to sHB-
EGF, but the majority of proHB-EGF molecules on the cell
surface seems to be internalized without shedding (Goishi et
al., 1995). In the case of HB
 tm, most synthesized molecules
would be secreted without shedding, resulting in oversecre-
tion of sHB-EGF even though the native HB-EGF pro-
moter regulates gene expression. Therefore, dysregulated se-
cretion of sHB-EGF would result in severe developmental
abnormalities. The present study thus confirms the notion
that ectodomain shedding of proHB-EGF must be strictly
controlled in vivo.
One question regarding the truncated HB
 tm mutant con-
cerns whether the observed hyperplasia might be due to an
intracrine rather than a paracrine mechanism. A transmem-
brane domain–truncated EGF mutant was reported to acti-
vate EGFR in an intracrine manner, as a result of interaction
with EGFR within cytoplasmic vesicles, before the mole-
cules reached the cell surface (Wiley et al., 1998). However,
this was not the case for HB-EGF. We have performed ex
vivo transfection of HB
 tm cDNA into mouse embryonic
skin (Fig. S3 and supplemental Results, available at http://
www.jcb.org/cgi/content/full/jcb.200307035/DC1). Trans-
fection of HB
 tm, but not WT proHB-EGF, resulted in em-
bryonic epidermal hyperplasia. CRM197, a protein that
specifically inhibits the mitogenic activity of HB-EGF (Mi-
tamura et al., 1995), inhibited HB- TM–induced hyper-
plasia. As CRM197 is membrane impermeable, hyperplasia
induced by transfection with HB
 tm must be mediated by se-
creted HB- TM in a paracrine manner.
In conclusion, proHB-EGF shedding and the strict con-
trol of this process are essential for the function of this
growth factor. Not only HB-EGF, but also other EGF fam-
ily growth factors and cytokines are synthesized as mem-
brane-anchored forms. The present study suggests that the
strict control of ectodomain shedding is essential for the
physiological function of these membrane-anchored ligands.
This study also indicates that posttranslational regulation, in
addition to transcriptional control, is crucial for the function
of membrane-anchored growth factors.
Materials and methods
Northern blotting
Total RNA was isolated from tissues using ISOGEN (Nippon Gene), ac-
cording to the manufacturer’s instructions. Details of the hybridization pro-
cedure are shown in the supplemental Materials and methods (available at
http://www.jcb.org/cgi/content/full/jcb.200307035/DC1).
Immunoblotting of tissues
For the detection of HB-EGF and HB-UC in adult skin, back skin from 11-
wk-old HB
lox/lox and HB
uc/uc mice was treated with 800 nmol of tRA for 3 d.
2 h before specimen isolation, the back skin was additionally treated with
8 nmol of TPA. The isolated full back skin was homogenized in lysis buffer
(Iwamoto et al., 2003). For detection of HB- TM in neonatal skin, skin
from P1 HB
 tm heterozygous mice or WT littermates was homogenized in
lysis buffer. Details of the immunoblotting procedure using these lysate
samples are shown in the supplemental Materials and methods (available
at http://www.jcb.org/cgi/content/full/jcb.200307035/DC1).
Histological analysis
Mouse hearts were fixed by perfusion with 4% paraformaldehyde, dehy-
drated, and embedded in paraffin. 4- m sections were stained with
either hematoxylin-eosin or Azan-Mallory. For immunohistochemical
analysis of transplanted skin, specimens of full-thickness skin (2–3 cm
2)
were transplanted onto the backs of Balb/c nu/nu mice (8 wk old) and
then fixed with adhesive bandages for 1 wk. 2 wk after transplantation,
skin specimens were isolated from the grafted skin and subjected to im-
munohistochemical analysis. Information of the used antibodies for im-
munohistochemistry, microscopy, and image processing is shown in the
supplemental Materials and methods (available at http://www.jcb.org/
cgi/content/full/jcb.200307035/DC1).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
Significance of proHB-EGF ectodomain shedding | Yamazaki et al. 475
Echocardiography
Transthoracic echocardiograph was performed with a cardiac ultrasound
recorder (SONOS 5500; Hewlett-Packard) with a 15-MHz transducer, as
described previously (Iwamoto et al., 2003).
RT-PCR
RNA was isolated from tissues of P14 mice using TRIzol reagent (Invitro-
gen). Reverse transcription was performed using a reverse transcriptase,
ReverTra Dash (TOYOBO). Primer sets used in PCR analyses are shown in
the supplemental Materials and methods (available at http://www.jcb.org/
cgi/content/full/jcb.200307035/DC1).
Online supplemental material
The supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200307035/DC1. Fig. S1 shows the characterizations of HB-UC
and HB- TM. Fig. S2 shows the targeting construct of HB
uc and HB
 tm and
genotypic analyses. Fig. S3 shows ex vivo transfection of HB
 tm cDNA into
mouse embryonic skin. Supplemental Results, Materials and methods, and
References are also presented.
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